Companies similar to T-KNIFE THERAPEUTICS
Sign up to Download

1-30 of 6,715,678 results

  • www.t-knife.com
  • 3
  • 3
  • 12
T-knife Therapeutics is a biopharmaceutical company dedicated to developing novel therapeutics to fight cancer... We are focused on T cell receptor engineered T cell therapies, TCR-Ts, a promising modality that holds the potential to generate..
Relevance: 38.808296
  • www.eurekatherapeutics.com
  • 3
  • 1
  • 16
Eureka Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative technology platforms that can access cancer-specific targets and harness the evolutionary power of T cells for the treatment of solid tumors and other..
Relevance: 36.994106
  • avencell.com
  • 4
  • 2
  • 20
AvenCell is collaborating with a number of partners committed to the joint development of novel immunotherapies based on our next generation platform technologies. We are open to exploring new clinical or strategic collaborations... AvenCell..
Relevance: 34.21206
  • poseida.com
  • 5
  • 2
  • 33
Poseida Therapeutics is a clinical-stage biopharmaceutical company advancing differentiated cell and gene therapies with the capacity to cure certain cancers and rare diseases. The Company's pipeline includes allogeneic CAR-T cell therapy product..
Relevance: 31.2065
  • tailored-therapeutics.com
  • 1
TAILORED THERAPEUTICS is an innovative cell therapy company focused on development of cancer treatments sourced from a patient's own immune system cells. TAILORED THERAPEUTICS has developed a portfolio of products based on tumor infiltrating..
Relevance: 31.099115
  • pharmtechfocus.com
  • 3
  • 18
Quince Therapeutics, a biopharmaceutical company advancing innovative precision therapeutics targeting debilitating and rare diseases, announced... BioSenic, the clinical stage company specializing in serious autoimmune/inflammatory diseases and..
Relevance: 30.944714
  • www.incellart.com
  • 1
  • 1
  • 5
In-Cell-Art is a biopharmaceutical company specializing in the preclinical and pharmaceutical development of nanocarriers named Nanotaxi® for macromolecular drugs... In-Cell-Art, is a biopharmaceutical company specializing in the preclinical and..
Relevance: 30.403929
  • medisixtx.com
  • 9
Visionary scientist and creator of the first anti-CD19 CAR, Professor Dario Campana established MediSix Therapeutics in 2016 to help patients with complex and rare T-cell malignancies... We believe that T-cell therapies will radically change the..
Relevance: 29.431274
  • www.barinthusbio.com
  • 1
  • 19
Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company focused on the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer... Barinthus..
Relevance: 29.301146
  • kyvernatx.com
  • 7
  • 1
  • 19
Kyverna is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases... Kyverna is pioneering CAR T-cell therapies for autoimmune disease patients by harnessing..
Relevance: 29.24598
  • cyclacel.com
  • 4
  • 3
  • 10
Cyclacel is a pioneer in the field of cell cycle biology to treat cancer. We use insights in cancer biology to research and develop medicines that address the growing problem of resistance. Cancer cells learn to evade anticancer therapeutics and..
Relevance: 29.167831
  • www.abeonatherapeutics.com
  • 2
  • 1
  • 19
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Abeona's lead clinical program is EB-101, its investigational autologous, gene-corrected cell therapy for recessive..
Relevance: 29.041445
  • immunecyte.com
  • 1
  • 2
ImmuneCyte is a clinical stage cell therapy company focused on delivering critical impacts on cancer, vascular, orthopedic, and aging-related diseases... ImmuneCyte Inc. is a global, clinical-stage biopharmaceutical company engaged in the research..
Relevance: 28.507242
  • villaristherapeutics.com
  • 1
  • 9
Villaris Therapeutics is a preclinical-stage biopharmaceutical company focused on developing novel antibody therapeutics for the treatment of vitiligo... Villaris Therapeutics is developing a novel humanized anti-IL-15R antibody to target depletion..
Relevance: 28.393234
  • www.axistherapeutics.com
  • 1
  • 14
Axis Therapeutics is a leading cancer immunotherapy company focused on the development of T cell therapies... Axis Therapeutics is developing cell-based therapies that take advantage of the unique attributes of TCR mediated target recognition...
Relevance: 28.239206
  • www.gracellbio.com
  • 2
  • 1
Gracell Biotechnologies is a global clinical-stage biopharmaceutical company dedicated to discovering and developing innovative and highly efficacious cell therapy. Leveraging its pioneering FasTCAR and TruUCAR technology platforms, Gracell is..
Relevance: 28.10591
  • verismotherapeutics.com
  • 2
  • 13
Verismo Therapeutics is pioneering CAR T-cell therapy for the treatment of solid tumors. This paradigm-shifting technology features a unique KIR-CAR construct that has been proven to reduce T-cell exhaustion and kill solid tumor models in in vivo..
Relevance: 27.903593
  • www.amniotics.com
  • 5
  • 2
  • 7
Amniotics is now in clinical phase with the leading drug candidate PulmoStem™ targeting severe lung diseases and is looking to establish strategic partnerships with researchers and companies that are interested in developing stem-cell-based therapies..
Relevance: 27.688154
  • signablok.com
  • 1
  • 1
SignaBlok, Inc. is a biopharmaceutical company founded in 2009 to develop novel mechanism-based targeted therapeutics and delivery nanosystems through the use of our revolutionary science and technologies... SignaBlok's elegant approach for..
Relevance: 27.414566
  • www.p53reactivation.com
  • 1
  • 1
Aprea Therapeutics is a biopharmaceutical company focused on developing novel cancer therapeutic candidates with the potential to reactivate mutant p53 protein... p53 is a tumor suppressor protein that regulates a complex network of signals that can..
Relevance: 27.161291
  • www.plasfer.bio
  • 1
  • 1
  • 7
Plasfer Srl is a pre-clinical stage biopharmaceutical company specialized in the development of a transformative cell-based therapy using a proprietary platform technology able to engineer platelet concentrate into highly innovative, life-changing..
Relevance: 27.157417
  • www.protagene.com
  • 3
  • 5
  • 10
ProtaGene is excited to announce our expanded molecular bioanalytical solutions capacity and capabilities - explicitly tailored for gene therapy developers. Our molecular bioanalytical solutions are designed to enable preclinical assessment of safety..
Relevance: 27.011059
  • www.centurytx.com
  • 3
  • 7
Century Therapeutics is an innovative biotechnology company that is building an industry leading allogeneic iPSC-derived cell therapy platform that integrates cutting-edge gene editing, protein engineering, technical development, and manufacturing..
Relevance: 26.997704
  • advantx.org
  • 4
  • 1
  • 2
Advantx is a person-centered biopharmaceutical company focused on developing disease-modifying therapeutics for neurological disorders through a deep understanding of protein mechanisms... Advantx is a New York-based clinical-stage biopharmaceutical..
Relevance: 26.881817
  • aertherapeutics.com
  • 1
  • 1
  • 23
Aer Therapeutics is a clinical-stage biopharmaceutical company dedicated to delivering a therapeutic solution to patients suffering from muco-obstructive lung diseases... Aer Therapeutics, a clinical-stage biopharmaceutical company developing..
Relevance: 26.853083
  • www.opexatherapeutics.com
  • 3
  • 1
  • 10
Opexa Therapeutics, Inc. (NASDAQ:OPXA) is a publically traded biotechnology company developing a personalized immunotherapy with the potential to treat major illnesses, including multiple sclerosis (MS) as well as other autoimmune diseases such as..
Relevance: 26.803505
  • triumvira.com
  • 1
  • 6
  • 12
Triumvira is developing unique, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat a broad range of patients with cancer... Our partners have independently validated our technology in..
Relevance: 26.717918
  • www.harpoontx.com
Harpoon Therapeutics is an immuno-oncology company using a proprietary technology platform focused on T cell engagement to discover and develop novel biologics for the treatment of cancer and other diseases... Effective March 11, 2024, Harpoon..
Relevance: 26.712385
  • www.tranquis.com
  • 3
  • 2
  • 9
Tranquis Therapeutics is led by an accomplished team of industry veterans with decades of entrepreneurial and R&D experience and specialized expertise in immunology, cell metabolism, mitochondrial biology and neurodegenerative diseases. We are..
Relevance: 26.60625
  • www.liminatuspharma.com
  • 1
Liminatus Pharma is well-positioned to become a leader on Guanylyl Cyclase C (GCC) CAR-T therapeutics with a promising focus towards a GCC vaccine... We are a clinical stage immuno-oncology company that develops chimeric antigen receptors (CAR)-T..
Relevance: 26.553911